|
DK3219705T3
(da)
|
2005-12-28 |
2020-04-14 |
Vertex Pharma |
Farmaceutiske sammensætninger af den amorfe form af n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinolin-3-carboxamid
|
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
|
CA2711558C
(en)
|
2008-01-04 |
2016-12-13 |
Intellikine, Inc. |
Phosphatidyl inositol-3 kinase inhibiting compounds
|
|
EP2845856A1
(en)
|
2009-06-29 |
2015-03-11 |
Incyte Corporation |
Pyrimidinones as PI3K inhibitors
|
|
US8759359B2
(en)
|
2009-12-18 |
2014-06-24 |
Incyte Corporation |
Substituted heteroaryl fused derivatives as PI3K inhibitors
|
|
EP2552208A4
(en)
*
|
2010-03-31 |
2014-07-09 |
Glaxo Group Ltd |
IMIDAZOLYL-IMIDAZOLES AS KINASE INHIBITORS
|
|
EP2558463A1
(en)
|
2010-04-14 |
2013-02-20 |
Incyte Corporation |
Fused derivatives as i3 inhibitors
|
|
WO2011163195A1
(en)
|
2010-06-21 |
2011-12-29 |
Incyte Corporation |
Fused pyrrole derivatives as pi3k inhibitors
|
|
US20140031547A1
(en)
*
|
2010-12-14 |
2014-01-30 |
Electrophoretics Limited |
CASEIN KINASE 1delta (CK 1delta) INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODE-GENERATIVE DISEASES SUCH AS TAUOPATHIES
|
|
TW201249844A
(en)
|
2010-12-20 |
2012-12-16 |
Incyte Corp |
N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors
|
|
WO2012088266A2
(en)
|
2010-12-22 |
2012-06-28 |
Incyte Corporation |
Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
|
|
AU2012205669B2
(en)
|
2011-01-10 |
2015-08-20 |
Infinity Pharmaceuticals Inc. |
Processes for preparing isoquinolinones and solid forms of isoquinolinones
|
|
WO2012125629A1
(en)
|
2011-03-14 |
2012-09-20 |
Incyte Corporation |
Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors
|
|
GB201104267D0
(en)
|
2011-03-14 |
2011-04-27 |
Cancer Rec Tech Ltd |
Pyrrolopyridineamino derivatives
|
|
US9126948B2
(en)
|
2011-03-25 |
2015-09-08 |
Incyte Holdings Corporation |
Pyrimidine-4,6-diamine derivatives as PI3K inhibitors
|
|
AR087701A1
(es)
|
2011-08-31 |
2014-04-09 |
Japan Tobacco Inc |
Derivados de pirazol con actividad inhibidora de sglt1
|
|
UA121539C2
(uk)
|
2011-09-02 |
2020-06-25 |
Інсайт Холдинґс Корпорейшн |
Гетероцикліламіни як інгібітори рі3к
|
|
CA2851087C
(en)
|
2011-10-07 |
2019-09-24 |
Takeda Pharmaceutical Company Limited |
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
|
|
LT2772484T
(lt)
|
2011-10-18 |
2017-12-27 |
Astellas Pharma Inc. |
Biciklinis heterociklinis junginys
|
|
AR090037A1
(es)
|
2011-11-15 |
2014-10-15 |
Xention Ltd |
Derivados de tieno y/o furo-pirimidinas y piridinas inhibidores de los canales de potasio
|
|
JP6141864B2
(ja)
|
2011-12-01 |
2017-06-07 |
ケモセントリックス，インコーポレイティド |
Ｃｃｒ（４）アンタゴニストとしての置換アニリン
|
|
AR090548A1
(es)
|
2012-04-02 |
2014-11-19 |
Incyte Corp |
Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
|
|
TWI633087B
(zh)
|
2012-06-13 |
2018-08-21 |
赫孚孟拉羅股份公司 |
新穎二氮雜螺環烷及氮雜螺環烷
|
|
LT3495367T
(lt)
|
2012-06-13 |
2021-02-25 |
Incyte Holdings Corporation |
Pakeistieji tricikliniai junginiai, kaip fgfr inhibitoriai
|
|
US8828998B2
(en)
|
2012-06-25 |
2014-09-09 |
Infinity Pharmaceuticals, Inc. |
Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
|
|
JP6299591B2
(ja)
*
|
2012-07-03 |
2018-03-28 |
小野薬品工業株式会社 |
ソマトスタチン受容体作動活性を有する化合物およびその医薬用途
|
|
WO2014009891A1
(en)
*
|
2012-07-11 |
2014-01-16 |
Piramal Enterprises Limited |
Heterocyclic compounds for use in the treatment of cancers
|
|
WO2014026125A1
(en)
|
2012-08-10 |
2014-02-13 |
Incyte Corporation |
Pyrazine derivatives as fgfr inhibitors
|
|
DK2888010T3
(da)
|
2012-08-22 |
2021-06-28 |
Univ Cornell |
Fremgangsmåder til at hæmme fascin
|
|
JP6219955B2
(ja)
*
|
2012-08-24 |
2017-10-25 |
トレヴェンティス コーポレイションＴｒｅｖｅｎｔｉｓ Ｃｏｒｐｏｒａｔｉｏｎ |
ベンゾフラザン抗アミロイド化合物および方法
|
|
CN102850341B
(zh)
*
|
2012-09-05 |
2015-02-18 |
浙江工业大学 |
一种噻二唑类化合物及其制备与应用
|
|
GB201216018D0
(en)
|
2012-09-07 |
2012-10-24 |
Cancer Rec Tech Ltd |
Pharmacologically active compounds
|
|
EP3590940B1
(en)
|
2012-09-25 |
2021-06-09 |
F. Hoffmann-La Roche AG |
Hexahydropyrrolo[3,4-c]pyrrole derivatives and related compounds as autotaxin (atx) inhibitors and as inhibitors of the lysophosphatidic acid (lpa) production for treating e.g. renal diseases
|
|
CN103739594A
(zh)
*
|
2012-10-17 |
2014-04-23 |
南京大学 |
一类含吡嗪环和三氮唑结构的席夫碱类衍生物及其制法
|
|
KR102229478B1
(ko)
|
2012-11-01 |
2021-03-18 |
인피니티 파마슈티칼스, 인코포레이티드 |
Pi3 키나아제 동형단백질 조절인자를 사용하는 암의 치료
|
|
RU2672916C2
(ru)
|
2012-11-27 |
2018-11-21 |
Томас Хелледайс Стифтелсе Фёр Медисинск Форскнинг |
Производные пиримидин-2,4-диамина для лечения рака
|
|
US9266892B2
(en)
|
2012-12-19 |
2016-02-23 |
Incyte Holdings Corporation |
Fused pyrazoles as FGFR inhibitors
|
|
US20150329540A1
(en)
|
2012-12-28 |
2015-11-19 |
Shin Nippon Biomedical Laboratories, Ltd. |
Oct3 activity inhibitor containing imidazopyridine derivative as active component, and oct3 detection agent
|
|
NZ710444A
(en)
|
2013-02-11 |
2020-08-28 |
Univ California |
Compositions and methods for treating neurodegenerative diseases and cardiomyopathy
|
|
AR095079A1
(es)
|
2013-03-12 |
2015-09-16 |
Hoffmann La Roche |
Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo
|
|
US9045477B2
(en)
|
2013-03-15 |
2015-06-02 |
Epizyme, Inc. |
Substituted 6,5-fused bicyclic heteroaryl compounds
|
|
JP2016520532A
(ja)
|
2013-03-15 |
2016-07-14 |
ホワイトヘッド・インスティテュート・フォー・バイオメディカル・リサーチ |
ベンゾイミダゾール誘導体およびその使用
|
|
US9776996B2
(en)
|
2013-03-15 |
2017-10-03 |
Epizyme, Inc. |
Substituted 6,5-fused bicyclic heteroaryl compounds
|
|
LT2986610T
(lt)
|
2013-04-19 |
2018-04-10 |
Incyte Holdings Corporation |
Bicikliniai heterociklai, kaip fgfr inhibitoriai
|
|
US9797882B2
(en)
|
2013-07-09 |
2017-10-24 |
The Translational Genomics Research Institute |
Method of screening for a compound for inhibitory activity of FN14-tweak interaction
|
|
EP3019874B1
(en)
*
|
2013-07-09 |
2019-08-21 |
The Translational Genomics Research Institute |
Compositions and methods of screening for compounds that modulate activity at a tweak binding site on a crd of fn14
|
|
TWI649308B
(zh)
|
2013-07-24 |
2019-02-01 |
小野藥品工業股份有限公司 |
喹啉衍生物
|
|
GB201314452D0
(en)
|
2013-08-13 |
2013-09-25 |
Ostara Biomedical Ltd |
Embryo implantation
|
|
RU2570907C2
(ru)
*
|
2013-10-21 |
2015-12-20 |
Автономная Некоммерческая Организация "Научно-Исследовательский Центр Биотехнологии Антибиотиков И Других Биологически Активных Веществ "Биоан" |
Производные 3-ациламинопиридин-2(1h)-она, применимые как ингибиторы серин-треониновой протеинкиназы gsk3b в качестве лекарственных препаратов для лечения диабета ii типа.
|
|
CA2929858C
(en)
|
2013-11-22 |
2022-03-29 |
CL BioSciences LLC |
Gastrin antagonists (eg yf476, netazepide) for treatment and prevention of osteoporosis
|
|
NO3074400T3
(enExample)
|
2013-11-26 |
2018-04-14 |
|
|
|
GB201321738D0
(en)
*
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic Agents
|
|
WO2015106025A1
(en)
*
|
2014-01-09 |
2015-07-16 |
The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone |
Substituted benzoxazine and related compounds
|
|
US9815841B2
(en)
|
2014-01-29 |
2017-11-14 |
Glaxosmithkline Intellectual Property Development Limited |
Compounds
|
|
KR20160106622A
(ko)
|
2014-01-29 |
2016-09-12 |
글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 |
화합물
|
|
CA2939219C
(en)
|
2014-02-11 |
2023-02-28 |
Mitokinin Llc |
Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease
|
|
KR102421235B1
(ko)
|
2014-02-13 |
2022-07-15 |
인사이트 코포레이션 |
Lsd1 저해제로서 사이클로프로필아민
|
|
EP3392244A1
(en)
|
2014-02-13 |
2018-10-24 |
Incyte Corporation |
Cyclopropylamines as lsd1 inhibitors
|
|
NZ723203A
(en)
|
2014-02-13 |
2020-08-28 |
Incyte Corp |
Cyclopropylamines as lsd1 inhibitors
|
|
US9527835B2
(en)
|
2014-02-13 |
2016-12-27 |
Incyte Corporation |
Cyclopropylamines as LSD1 inhibitors
|
|
WO2015127125A1
(en)
|
2014-02-20 |
2015-08-27 |
Cornell University |
Compounds and methods for inhibiting fascin
|
|
RS58976B1
(sr)
*
|
2014-02-27 |
2019-08-30 |
Treventis Corp |
Antiamiloidna jedinjenja koja sadrže benzofuran
|
|
EP3122751B1
(en)
|
2014-03-26 |
2019-10-30 |
F.Hoffmann-La Roche Ag |
Condensed [1,4]diazepine compounds as autotaxin (atx) and lysophosphatidic acid (lpa) production inhibitors
|
|
MA39792B1
(fr)
|
2014-03-26 |
2019-12-31 |
Hoffmann La Roche |
Composés bicycliques en tant qu'inhibiteurs de production d'autotaxine (atx) et d'acide lysophosphatidique (lpa)
|
|
US20170029388A1
(en)
*
|
2014-04-11 |
2017-02-02 |
Intercontinental Great Brands Llc |
Treatment of Neurodegenerative Diseases with Asparagine Endopeptidase (AEP) Inhibitors and Compositions Related Thereto
|
|
US20150320755A1
(en)
|
2014-04-16 |
2015-11-12 |
Infinity Pharmaceuticals, Inc. |
Combination therapies
|
|
CN105085436B
(zh)
*
|
2014-04-19 |
2019-08-16 |
广东东阳光药业有限公司 |
磺酰胺类衍生物及其在药物上的应用
|
|
EP3134413B1
(en)
|
2014-04-23 |
2019-09-11 |
Dart NeuroScience (Cayman) Ltd. |
Substituted [1,2,4]triazolo[1,5-a]pyrimidin-7-yl compounds as pde2 inhibitors
|
|
EP3140298A1
(en)
|
2014-05-07 |
2017-03-15 |
Pfizer Inc. |
Tropomyosin-related kinase inhibitors
|
|
CN104059060B
(zh)
*
|
2014-05-30 |
2017-08-01 |
西安交通大学 |
一种5‑(1h‑吲哚‑3‑亚甲基)‑1,3‑噻唑烷‑4‑酮类衍生物及其合成方法和应用
|
|
CA2949785A1
(en)
|
2014-06-04 |
2015-12-10 |
Thomas Helledays Stiftelse For Medicinsk Forskning |
Mth1 inhibitors for treatment of cancer
|
|
CN106794181A
(zh)
|
2014-06-04 |
2017-05-31 |
托马斯·黑勒戴药物研究基金会 |
用于治疗炎性和自身免疫性病况的mth1抑制剂
|
|
US10077277B2
(en)
|
2014-06-11 |
2018-09-18 |
Incyte Corporation |
Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors
|
|
US9758523B2
(en)
|
2014-07-10 |
2017-09-12 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as LSD1 inhibitors
|
|
WO2016007722A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as lsd1 inhibitors
|
|
WO2016007731A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Imidazopyridines and imidazopyrazines as lsd1 inhibitors
|
|
US9695180B2
(en)
|
2014-07-10 |
2017-07-04 |
Incyte Corporation |
Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors
|
|
JP6571756B2
(ja)
|
2014-07-31 |
2019-09-04 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ |
神経変性疾患に適応可能なインドリジン誘導体
|
|
JP2017523211A
(ja)
|
2014-08-04 |
2017-08-17 |
ドレクセル ユニバーシティ |
新規化合物およびそれを用いてｉｌ−１ｒ媒介性の疾患または障害を処置するかまたは寛解させる方法
|
|
JO3589B1
(ar)
|
2014-08-06 |
2020-07-05 |
Novartis Ag |
مثبطات كيناز البروتين c وطرق استخداماتها
|
|
CN107250113B
(zh)
|
2014-10-07 |
2019-03-29 |
弗特克斯药品有限公司 |
囊性纤维化跨膜传导调节蛋白的调节剂的共晶
|
|
US10851105B2
(en)
|
2014-10-22 |
2020-12-01 |
Incyte Corporation |
Bicyclic heterocycles as FGFR4 inhibitors
|
|
GB201419579D0
(en)
*
|
2014-11-03 |
2014-12-17 |
Iomet Pharma Ltd |
Pharmaceutical compound
|
|
WO2016073424A1
(en)
|
2014-11-05 |
2016-05-12 |
Dart Neuroscience, Llc |
Substituted 5-methyl-[1, 2, 4] triazolo [1,5-a) pyrimidin-2-amine compounds as pde2 inhibitors
|
|
JP6708130B2
(ja)
|
2014-12-25 |
2020-06-10 |
小野薬品工業株式会社 |
キノリン誘導体
|
|
GB201501302D0
(en)
|
2015-01-27 |
2015-03-11 |
Ostara Biomedical Ltd |
Embryo implantation
|
|
MA41551A
(fr)
|
2015-02-20 |
2017-12-26 |
Incyte Corp |
Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
|
|
SG11201706287PA
(en)
|
2015-02-20 |
2017-09-28 |
Incyte Corp |
Bicyclic heterocycles as fgfr inhibitors
|
|
WO2016134294A1
(en)
|
2015-02-20 |
2016-08-25 |
Incyte Corporation |
Bicyclic heterocycles as fgfr4 inhibitors
|
|
UA122332C2
(uk)
|
2015-02-27 |
2020-10-26 |
Інсайт Корпорейшн |
Солі інгібітора pi3k і способи їх отримання
|
|
US10722513B2
(en)
*
|
2015-03-23 |
2020-07-28 |
The University Of Melbourne |
Treatment of respiratory diseases
|
|
UA122688C2
(uk)
|
2015-04-03 |
2020-12-28 |
Інсайт Корпорейшн |
Гетероциклічні сполуки як інгібітори lsd1
|
|
MA41898A
(fr)
|
2015-04-10 |
2018-02-13 |
Hoffmann La Roche |
Dérivés de quinazolinone bicyclique
|
|
AU2016254049A1
(en)
*
|
2015-04-30 |
2017-11-02 |
Musc Foundation For Research Development |
Oxindole compounds and pharmaceutical compositions thereof
|
|
WO2016183060A1
(en)
|
2015-05-11 |
2016-11-17 |
Incyte Corporation |
Process for the synthesis of a phosphoinositide 3-kinase inhibitor
|
|
WO2016183063A1
(en)
|
2015-05-11 |
2016-11-17 |
Incyte Corporation |
Crystalline forms of a pi3k inhibitor
|
|
GB201508276D0
(en)
|
2015-05-14 |
2015-06-24 |
Electrophoretics Ltd |
A casein kinase 1 delta inhibitor
|
|
GB201509134D0
(en)
|
2015-05-28 |
2015-07-15 |
Electrophoretics Ltd |
Biomolecules involved in Alzheimer's disease
|
|
MX2017015456A
(es)
*
|
2015-06-01 |
2018-11-29 |
Bantam Pharmaceutical Llc |
Compuestos de pirazol y pirrol sustituidos y metodos para su uso por inhibición de iniciación de traducción y tratamiento de enfermedades y trastornos relacionados con ellos.
|
|
WO2016202756A1
(en)
|
2015-06-18 |
2016-12-22 |
Bayer Pharma Aktiengesellschaft |
Substituted 2-(1h-pyrazol-1-yl)-1h-benzimidazole compounds
|
|
WO2016202758A1
(en)
|
2015-06-18 |
2016-12-22 |
Bayer Pharma Aktiengesellschaft |
Substituted 2-(1h-pyrazol-1-yl)-1h-benzimidazole compounds
|
|
JP2018525345A
(ja)
|
2015-07-01 |
2018-09-06 |
ノースウェスタン ユニバーシティ |
置換キナゾリン化合物及びグルコセレブロシダーゼ活性の調節のためのその使用
|
|
WO2017000277A1
(en)
|
2015-07-01 |
2017-01-05 |
Merck Sharp & Dohme Corp. |
Substituted triazolo bicycliccompounds as pde2 inhibitors
|
|
JP7427363B2
(ja)
|
2015-08-12 |
2024-02-05 |
インサイト・ホールディングス・コーポレイション |
Ｌｓｄ１阻害剤の塩
|
|
CN105061462B
(zh)
*
|
2015-08-18 |
2017-05-24 |
沈阳药科大学 |
含有酰胺的四氢苯并[4,5]噻吩并[2,3‑d]嘧啶类化合物及其应用
|
|
MX387736B
(es)
*
|
2015-09-04 |
2025-03-18 |
Hoffmann La Roche |
Derivados de fenoximetilo.
|
|
JP6469238B2
(ja)
|
2015-09-18 |
2019-02-13 |
科研製薬株式会社 |
ビアリール誘導体及びそれを含有する医薬
|
|
KR20180054634A
(ko)
|
2015-09-24 |
2018-05-24 |
에프. 호프만-라 로슈 아게 |
이중 오토탁신(atx)/탄산 무수화효소(ca) 억제제로서 신규한 이환형 화합물
|
|
MX2017015034A
(es)
|
2015-09-24 |
2018-04-13 |
Hoffmann La Roche |
Nuevos compuestos biciclicos como inhibidores duales de autotaxina (atx)/anhidrasa carbonica (ca).
|
|
CN107635995B
(zh)
|
2015-09-24 |
2022-08-19 |
豪夫迈·罗氏有限公司 |
作为atx抑制剂的二环化合物
|
|
PE20180451A1
(es)
|
2015-09-24 |
2018-03-05 |
Hoffmann La Roche |
Nuevos compuestos biciclicos como inhibidores de atx
|
|
US20190112317A1
(en)
|
2015-10-05 |
2019-04-18 |
The Trustees Of Columbia University In The City Of New York |
Activators of autophagic flux and phospholipase d and clearance of protein aggregates including tau and treatment of proteinopathies
|
|
GB201517523D0
(en)
|
2015-10-05 |
2015-11-18 |
Ostara Biomedical Ltd |
Methods and compositions for managing reproduction
|
|
WO2017063966A1
(en)
|
2015-10-13 |
2017-04-20 |
Bayer Pharma Aktiengesellschaft |
Substituted 2-(1h-pyrazol-1-yl)-benzothiazole compounds
|
|
UA122423C2
(uk)
*
|
2015-11-02 |
2020-11-10 |
Янссен Фармацевтика Нв |
[1,2,4]ТРИАЗОЛО[1,5-a]ПІРИМІДИН-7-ІЛЬНА СПОЛУКА
|
|
WO2017097182A1
(zh)
*
|
2015-12-07 |
2017-06-15 |
成都海创药业有限公司 |
喹啉类化合物及其制备方法和作为尿酸盐转运体抑制剂类药物的用途
|
|
WO2017106367A1
(en)
*
|
2015-12-15 |
2017-06-22 |
D.E. Shaw Research, Llc |
Method of treating neurodegenerative disorders by rescuing alpha-synuclein toxicity
|
|
WO2017133258A1
(zh)
*
|
2016-02-04 |
2017-08-10 |
西华大学 |
1h-吲唑类衍生物及其作为ido抑制剂的用途
|
|
CN107033087B
(zh)
*
|
2016-02-04 |
2020-09-04 |
西华大学 |
1h-吲唑-4-胺类化合物及其作为ido抑制剂的用途
|
|
CN107840826B
(zh)
*
|
2016-09-19 |
2021-07-09 |
西华大学 |
1h-吲唑类衍生物及其作为ido抑制剂的用途
|
|
US10166221B2
(en)
|
2016-04-22 |
2019-01-01 |
Incyte Corporation |
Formulations of an LSD1 inhibitor
|
|
US10774064B2
(en)
|
2016-06-02 |
2020-09-15 |
Cadent Therapeutics, Inc. |
Potassium channel modulators
|
|
EA202092442A3
(ru)
|
2016-06-07 |
2021-08-31 |
Джакобио Фармасьютикалс Ко., Лтд. |
Новые гетероциклические производные, применимые в качестве ингибиторов shp2
|
|
MX391135B
(es)
|
2016-06-24 |
2025-03-21 |
Infinity Pharmaceuticals Inc |
Terapias de combinacion.
|
|
MX2019000536A
(es)
|
2016-07-14 |
2019-04-01 |
Pfizer |
Nuevas pirimidinas carboxamidas como inhibidores de enzima vanina-1.
|
|
WO2018030762A1
(ko)
*
|
2016-08-09 |
2018-02-15 |
세종대학교산학협력단 |
Ampk 억제기능에 기반한 뇌졸중 치료용 약학적 조성물
|
|
CA3034211A1
(en)
|
2016-08-18 |
2018-02-22 |
Vidac Pharma Ltd. |
Piperazine derivatives, pharmaceutical compositions and methods of use thereof
|
|
EP3872080B1
(en)
|
2016-09-02 |
2023-08-16 |
Cyclerion Therapeutics, Inc. |
Fused bicyclic sgc stimulators
|
|
CN106432235B
(zh)
*
|
2016-10-19 |
2018-02-02 |
南通大学 |
靶向CDK和DNA的β‑咔啉衍生物及其制备方法和医药用途
|
|
JP2019533022A
(ja)
|
2016-10-24 |
2019-11-14 |
ユマニティ セラピューティクス，インコーポレーテッド |
化合物及びその使用
|
|
KR20190071721A
(ko)
|
2016-11-02 |
2019-06-24 |
얀센 파마슈티카 엔.브이. |
Pde2 억제제로서의 [1,2,4]트리아졸로[1,5-a]피리미딘 화합물
|
|
UA125302C2
(uk)
*
|
2016-11-02 |
2022-02-16 |
Янссен Фармацевтика Нв |
Похідні [1,2,4]триазоло[1,5-a]піримідину як інгібітори pde2
|
|
MA46690A
(fr)
*
|
2016-11-02 |
2019-09-11 |
Janssen Pharmaceutica Nv |
Composés de [1,2,4]triazolo [1,5-a]pyrimidine en tant qu'inhibiteurs de pde2
|
|
US11008325B2
(en)
|
2016-11-14 |
2021-05-18 |
Virginia Commonwealth University |
Inhibitors of cancer invasion, attachment, and/or metastasis
|
|
US20190358238A1
(en)
*
|
2016-11-16 |
2019-11-28 |
University Of South Florida |
ALLOSTERIC ANTAGONISTS OF GPRC6a AND THEIR USE IN MITIGATING PROTEINOPATHIES
|
|
CA3049010A1
(en)
|
2017-01-06 |
2018-07-12 |
Yumanity Therapeutics, Inc. |
Methods for the treatment of neurological disorders
|
|
CN116462666B
(zh)
*
|
2017-01-10 |
2025-07-15 |
瑞士苏黎世联邦理工学院 |
细胞保护性化合物及其用途
|
|
CN106831573B
(zh)
*
|
2017-01-23 |
2019-05-24 |
南阳师范学院 |
(n-1,2,3,4-四氢异喹啉基)-阿魏酰胺化合物、制备方法及其应用
|
|
CN106748969B
(zh)
*
|
2017-01-23 |
2019-06-18 |
南阳师范学院 |
一种n-(4-苄基哌啶基)-阿魏酰胺化合物、制备方法及其用途
|
|
BR112019014814B1
(pt)
|
2017-01-23 |
2024-03-12 |
Novartis Ag |
Compostos, composições farmacêuticas dos mesmos e seus usos no tratamento de doenças associadas à disfunção de canais iônicos de potássio
|
|
ES2872923T3
(es)
|
2017-01-26 |
2021-11-03 |
Ono Pharmaceutical Co |
Sal etanosulfonato de N-{5-[(6,7-dimetoxi-4-quinolinil)oxi]-2-piridinil}-2,5-dioxo-1-fenil-1,2,5,6,7,8-hexahidro-3-quinolinacarboxamida
|
|
NZ755447A
(en)
*
|
2017-02-01 |
2023-05-26 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
N1 -(4-(5-(cyclopropylmethyl)-1 -methyl-1 h-pyrazol-4-yl)pyridin-2-yl)cyclohexane-1,4-diamine derivatives and related compounds as ck1 and/or iraki inhibitors for treating cancer
|
|
CN109730996B
(zh)
*
|
2017-03-01 |
2021-08-24 |
浙江大学 |
喹啉结构类型雄激素受体拮抗剂及其应用
|
|
MA49879A
(fr)
|
2017-03-16 |
2020-06-24 |
Hoffmann La Roche |
Composés hétérocycliques utiles en tant qu'inhibiteurs doubles d'atx/ca
|
|
CN110382484B
(zh)
|
2017-03-16 |
2022-12-06 |
豪夫迈·罗氏有限公司 |
新的作为atx抑制剂的二环化合物
|
|
EP3680241A1
(en)
|
2017-03-20 |
2020-07-15 |
Forma Therapeutics, Inc. |
Pyrrolopyrrole compositions as pyruvate kinase (pkr) activators
|
|
WO2018172984A1
(en)
|
2017-03-23 |
2018-09-27 |
Jacobio Pharmaceuticals Co., Ltd. |
Novel heterocyclic derivatives useful as shp2 inhibitors
|
|
MX2021011775A
(es)
|
2017-04-26 |
2023-01-10 |
Basilea Pharm Int Ag |
Procesos para la preparacion de furazanobencimidazoles y formas cristalinas de estos.
|
|
EP3634406B1
(en)
*
|
2017-05-12 |
2023-09-06 |
Board of Trustees of The Southern Illinois University on behalf of Southern Illinois University Edwardsville |
3,4,5-trisubstituted-1,2,4-triazoles and 3,4,5-trisubstituted-3-thio-1,2,4-triazoles and uses thereof
|
|
AR111960A1
(es)
|
2017-05-26 |
2019-09-04 |
Incyte Corp |
Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
|
|
UY37759A
(es)
|
2017-06-09 |
2019-01-31 |
Novartis Ag |
Compuestos y composiciones para inducir condrogénesis
|
|
CN110997664A
(zh)
*
|
2017-06-14 |
2020-04-10 |
欧洲分子生物学实验室 |
用于疗法的苯并呋喃酰胺及其杂芳族类似物
|
|
KR20200019228A
(ko)
|
2017-06-21 |
2020-02-21 |
미토키닌, 인크. |
신경퇴행성 및 미토콘드리아 질환의 치료를 위한 조성물 및 이를 사용하는 방법
|
|
GB201710851D0
(en)
*
|
2017-07-06 |
2017-08-23 |
Galápagos Nv |
Novel compounds and pharmaceutical compositions thereof for the treatment of fibrosis
|
|
JP7258009B2
(ja)
|
2017-07-10 |
2023-04-14 |
セルジーン コーポレイション |
抗増殖化合物及びその使用方法
|
|
CA3069720A1
(en)
|
2017-07-11 |
2019-01-17 |
Vertex Pharmaceuticals Incorporated |
Carboxamides as modulators of sodium channels
|
|
JP7159173B2
(ja)
|
2017-09-11 |
2022-10-24 |
保土谷化学工業株式会社 |
ピリミジン環構造を有する化合物および有機エレクトロルミネッセンス素子
|
|
WO2019055877A1
(en)
|
2017-09-15 |
2019-03-21 |
Forma Therapeutics, Inc. |
TETRAHYDROIMIDAZO QUINOLINE COMPOSITIONS AS INHIBITORS OF CBP / P300
|
|
US11826363B2
(en)
|
2017-10-13 |
2023-11-28 |
Ono Pharmaceutical Co., Ltd. |
Therapeutic agent for solid cancers, which comprises Axl inhibitor as active ingredient
|
|
HUE070649T2
(hu)
|
2017-10-19 |
2025-06-28 |
Teijin Pharma Ltd |
Benzimidazol-származékok és felhasználásuk
|
|
CA3083000A1
(en)
|
2017-10-24 |
2019-05-02 |
Yumanity Therapeutics, Inc. |
Compounds and uses thereof
|
|
EP3728200A1
(en)
*
|
2017-12-21 |
2020-10-28 |
Gliapharm SA |
Compositions and methods of treatment for neurological disorders comprising motor neuron diseases
|
|
JP2021507945A
(ja)
*
|
2017-12-21 |
2021-02-25 |
グリアファーム エスエー |
認知症を含む神経障害のための組成物および治療方法
|
|
BR122023024273A2
(pt)
|
2018-02-27 |
2024-02-20 |
Incyte Corporation |
Compostos imidazopirimidinas e triazolopirimidinas, seus usos, método para inibir uma atividade de um receptor de adenosina e composição farmacêutica dos mesmos
|
|
EP3762383B1
(en)
*
|
2018-03-06 |
2023-12-06 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
Positive allosteric modulators of dopamine 1 receptor and method of use thereof
|
|
EP3543231A1
(en)
*
|
2018-03-19 |
2019-09-25 |
ETH Zurich |
Compounds for treating cns- and neurodegenerative diseases
|
|
CA3094527A1
(en)
|
2018-03-23 |
2019-09-26 |
Yumanity Therapeutics, Inc. |
Compounds and uses thereof
|
|
MX2020011718A
(es)
|
2018-05-04 |
2021-02-15 |
Incyte Corp |
Formas solidas de un inhibidor de receptores del factor de crecimiento de fibroblastos (fgfr) y procesos para prepararlas.
|
|
ES3061844T3
(en)
|
2018-05-04 |
2026-04-07 |
Incyte Corp |
Salts of an fgfr inhibitor
|
|
TWI815887B
(zh)
*
|
2018-05-15 |
2023-09-21 |
美商愛彼特生物製藥股份有限公司 |
經取代的2,2'-雙嘧啶基化合物、其類似物及其使用方法
|
|
EP3810610A1
(en)
|
2018-05-18 |
2021-04-28 |
Incyte Corporation |
Fused pyrimidine derivatives as a2a / a2b inhibitors
|
|
MX2020012826A
(es)
|
2018-06-01 |
2021-03-09 |
Incyte Corp |
Regimen de dosificacion para el tratamiento de trastornos relacionados con fosfatidilinositol 3-cinasas (pi3k).
|
|
GB201810092D0
(en)
|
2018-06-20 |
2018-08-08 |
Ctxt Pty Ltd |
Compounds
|
|
GB201810581D0
(en)
|
2018-06-28 |
2018-08-15 |
Ctxt Pty Ltd |
Compounds
|
|
KR20250067962A
(ko)
|
2018-06-29 |
2025-05-15 |
포르마 세라퓨틱스 인크. |
Creb 결합 단백질(cbp)의 저해
|
|
AU2019297361B2
(en)
|
2018-07-05 |
2024-06-27 |
Incyte Corporation |
Fused pyrazine derivatives as A2A / A2B inhibitors
|
|
MX2021001456A
(es)
*
|
2018-08-06 |
2021-05-27 |
Univ Leland Stanford Junior |
2-arilbenzimidazoles como activadores de ppargc1a para tratar enfermedades neurodegenerativas.
|
|
ES3064498T3
(enExample)
|
2018-08-29 |
2026-04-27 |
Chemocentryx Inc |
|
|
WO2020047198A1
(en)
|
2018-08-31 |
2020-03-05 |
Incyte Corporation |
Salts of an lsd1 inhibitor and processes for preparing the same
|
|
US11278527B2
(en)
|
2018-09-04 |
2022-03-22 |
Brown University |
Compositions and methods for the modulation of the corticotropin releasing factor binding protein and the treatment of alcohol use disorder
|
|
MX2021002652A
(es)
*
|
2018-09-09 |
2021-09-23 |
Qanatpharma Ag |
Uso de inhibidores de caseina-cinasa 1 para el tratamiento de enfermedades vasculares.
|
|
WO2020061103A1
(en)
|
2018-09-18 |
2020-03-26 |
Nikang Therapeutics, Inc. |
Fused tricyclic ring derivatives as src homology-2 phosphatase inhibitors
|
|
WO2020061255A1
(en)
|
2018-09-19 |
2020-03-26 |
Forma Therapeutics, Inc. |
Activating pyruvate kinase r
|
|
US10675274B2
(en)
|
2018-09-19 |
2020-06-09 |
Forma Therapeutics, Inc. |
Activating pyruvate kinase R
|
|
CN112839935A
(zh)
|
2018-09-26 |
2021-05-25 |
北京加科思新药研发有限公司 |
可用作shp2抑制剂的新型杂环衍生物
|
|
AU2019366312B2
(en)
|
2018-10-22 |
2025-04-24 |
Novartis Ag |
Crystalline forms of potassium channel modulators
|
|
KR102880470B1
(ko)
*
|
2018-10-23 |
2025-11-03 |
다이이찌 산쿄 가부시키가이샤 |
바이아릴 유도체
|
|
EP3877382B1
(en)
|
2018-11-07 |
2026-03-18 |
Tianli Biotech Pty Ltd |
Novel compounds for the treatment of respiratory diseases
|
|
CN109503563B
(zh)
*
|
2018-12-10 |
2020-05-12 |
济南大学 |
多功能乙酰胆碱酯酶抑制剂及其应用
|
|
KR102128509B1
(ko)
|
2018-12-19 |
2020-07-01 |
한국과학기술연구원 |
말단 아민기에 아릴 또는 헤테로아릴기가 치환된 신규한 히드라존 유도체 및 이의 용도
|
|
US20220073470A1
(en)
*
|
2019-01-04 |
2022-03-10 |
Bellbrook Labs, Llc |
Inhibitors of cgas activity as therapeutic agents
|
|
WO2020146612A1
(en)
|
2019-01-10 |
2020-07-16 |
Vertex Pharmaceuticals Incorporated |
Esters and carbamates as modulators of sodium channels
|
|
WO2020146682A1
(en)
|
2019-01-10 |
2020-07-16 |
Vertex Pharmaceuticals Incorporated |
Carboxamides as modulators of sodium channels
|
|
US12098146B2
(en)
|
2019-01-24 |
2024-09-24 |
Janssen Pharmaceutica Nv |
Compounds and uses thereof
|
|
TWI829857B
(zh)
|
2019-01-29 |
2024-01-21 |
美商英塞特公司 |
作為a2a / a2b抑制劑之吡唑并吡啶及三唑并吡啶
|
|
US11628162B2
(en)
|
2019-03-08 |
2023-04-18 |
Incyte Corporation |
Methods of treating cancer with an FGFR inhibitor
|
|
US12351577B2
(en)
|
2019-03-15 |
2025-07-08 |
Forma Therapeutics, Inc. |
Inhibiting cyclic AMP-responsive element-binding protein (CREB)
|
|
KR102939516B1
(ko)
|
2019-04-26 |
2026-03-16 |
셀진 코포레이션 |
헤테로시클릭 화합물 및 연충 감염 및 질환의 치료를 위한 그의 용도
|
|
UY38687A
(es)
|
2019-05-17 |
2023-05-15 |
Novartis Ag |
Inhibidores del inflamasoma nlrp3, composiciones, combinaciones de los mismos y métodos para su uso
|
|
PH12021553107A1
(en)
|
2019-06-18 |
2022-08-01 |
Ctxt Pty Ltd |
Benzisoxazole sulfonamide derivatives
|
|
US11591329B2
(en)
|
2019-07-09 |
2023-02-28 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
|
US11535621B2
(en)
|
2019-07-31 |
2022-12-27 |
Ribon Therapeutics, Inc. |
Heterobicyclic amides as inhibitors of CD38
|
|
RU2746423C2
(ru)
*
|
2019-09-02 |
2021-04-13 |
Общество с ограниченной ответственностью "Научно-исследовательский институт ХимРар" (ООО "НИИ ХимРар") |
Ингибитор вируса гепатита В (ВГВ)
|
|
HUE072832T2
(hu)
|
2019-09-19 |
2025-12-28 |
Novo Nordisk Healthcare Ag |
Piruvát kináz R-t (PKR) aktiváló készítmények
|
|
US12122767B2
(en)
|
2019-10-01 |
2024-10-22 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
|
TWI891666B
(zh)
|
2019-10-14 |
2025-08-01 |
美商英塞特公司 |
作為ｆｇｆｒ抑制劑之雙環雜環
|
|
US11566028B2
(en)
|
2019-10-16 |
2023-01-31 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
|
EA202192047A1
(ru)
|
2019-11-13 |
2021-12-08 |
Юманити Терапьютикс, Инк. |
Соединения и их применение
|
|
US12343335B2
(en)
|
2019-11-14 |
2025-07-01 |
Zincure Corp. |
Pharmaceutical composition for treating multiple sclerosis on basis of AMPK inhibitory function and zinc homeostasis control function
|
|
WO2021113462A1
(en)
|
2019-12-04 |
2021-06-10 |
Incyte Corporation |
Derivatives of an fgfr inhibitor
|
|
CA3163875A1
(en)
|
2019-12-04 |
2021-06-10 |
Incyte Corporation |
Tricyclic heterocycles as fgfr inhibitors
|
|
MX2022006865A
(es)
|
2019-12-06 |
2022-07-11 |
Vertex Pharma |
Tetrahidrofuranos sustituidos como moduladores de canales de sodio.
|
|
US12012409B2
(en)
|
2020-01-15 |
2024-06-18 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
|
AR122711A1
(es)
*
|
2020-06-25 |
2022-09-28 |
Alchemedicine Inc |
COMPUESTO HETEROCÍCLICO COMO INHIBIDOR DE CASEÍNA QUINASA 1d Y/O QUINASA 5 TIPO RECEPTOR DE ACTIVINA
|
|
WO2022035805A1
(en)
*
|
2020-08-10 |
2022-02-17 |
Dana-Farber Cancer Institute, Inc. |
Substituted 1,2,4-oxadiazoles as small molecule inhibitors of ubiquitin-specific protease 28
|
|
US20230339900A1
(en)
*
|
2020-09-17 |
2023-10-26 |
Janssen Pharmaceutica Nv |
Casein kinase 1 delta modulators
|
|
US11801243B2
(en)
|
2020-09-23 |
2023-10-31 |
Forma Therapeutics, Inc. |
Bromodomain inhibitors for androgen receptor-driven cancers
|
|
US11795168B2
(en)
|
2020-09-23 |
2023-10-24 |
Forma Therapeutics, Inc. |
Inhibiting cyclic amp-responsive element-binding protein (CREB) binding protein (CBP)
|
|
GB202101734D0
(en)
*
|
2021-02-08 |
2021-03-24 |
Cerevance Inc |
Novel Compounds
|
|
JP2024507253A
(ja)
|
2021-02-19 |
2024-02-16 |
スドー バイオサイエンシーズ リミテッド |
Ｔｙｋ２阻害剤およびその使用
|
|
JP2024508794A
(ja)
|
2021-02-19 |
2024-02-28 |
スドー バイオサイエンシーズ リミテッド |
Ｔｙｋ２阻害剤およびその使用
|
|
CA3207819A1
(en)
|
2021-02-19 |
2022-08-25 |
Anjali Pandey |
Tyk2 inhibitors and uses thereof
|
|
US12128035B2
(en)
|
2021-03-19 |
2024-10-29 |
Novo Nordisk Health Care Ag |
Activating pyruvate kinase R
|
|
TW202304459A
(zh)
|
2021-04-12 |
2023-02-01 |
美商英塞特公司 |
包含ｆｇｆｒ抑制劑及ｎｅｃｔｉｎ－４靶向劑之組合療法
|
|
KR102910851B1
(ko)
*
|
2021-04-21 |
2026-01-09 |
장춘 진사이언스 파마슈티컬 씨오., 엘티디. |
이미다졸 함유 축합고리계 유도체, 이의 제조방법 및 이의 의약적 용도
|
|
CN117794920A
(zh)
|
2021-06-04 |
2024-03-29 |
沃泰克斯药物股份有限公司 |
N-(羟烷基(杂)芳基)四氢呋喃甲酰胺作为钠通道调节剂
|
|
EP4352060A1
(en)
|
2021-06-09 |
2024-04-17 |
Incyte Corporation |
Tricyclic heterocycles as fgfr inhibitors
|
|
JP2024522189A
(ja)
|
2021-06-09 |
2024-06-11 |
インサイト・コーポレイション |
Ｆｇｆｒ阻害剤としての三環式ヘテロ環
|
|
CA3233233A1
(en)
*
|
2021-10-15 |
2023-04-20 |
Ruben Abagyan |
Substituted 1h-pyrazolo [4,3-c] quinolines, methods of preparation, and use thereof
|
|
JP2025513455A
(ja)
|
2022-04-22 |
2025-04-24 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
疼痛の治療のためのヘテロアリール化合物
|
|
CN115466211B
(zh)
*
|
2022-06-09 |
2024-02-23 |
中国人民解放军空军军医大学 |
一种n-苯基喹啉-4-胺类化合物及其应用
|
|
JP2025525514A
(ja)
*
|
2022-07-14 |
2025-08-05 |
シャンハイ、レイジング、ファーマシューティカル、カンパニー、リミテッド |
Ｔｐｋアゴニスト及びそれを用いた神経変性疾患の治療方法
|
|
US12600723B2
(en)
|
2022-07-18 |
2026-04-14 |
Incyte Corporation |
Tetracyclic compounds as DGK inhibitors
|
|
US12600722B2
(en)
|
2022-07-18 |
2026-04-14 |
Incyte Corporation |
Tetracyclic compounds as DGK inhibitors
|
|
UY40374A
(es)
|
2022-08-03 |
2024-02-15 |
Novartis Ag |
Inhibidores de inflamasoma nlrp3
|
|
EP4574826A4
(en)
*
|
2022-10-19 |
2025-12-10 |
Changchun Genescience Pharmaceutical Co Ltd |
CRYSTALLINE FORM OF AN NK3R ANTAGONIST, ITS PREPARATION PROCESS AND ITS USE
|
|
CN120917015A
(zh)
*
|
2023-01-20 |
2025-11-07 |
元启(苏州)生物制药有限公司 |
Srpk1抑制剂和使用方法
|
|
EP4660182A1
(en)
*
|
2023-01-30 |
2025-12-10 |
Eurofarma Laboratórios S.A. |
Nav1.7- and/or nav1.8-inhibiting aryl pyridine compounds, processes for the preparation thereof, compositions, uses, methods for treatment using same, and kits
|
|
PY2404641A
(es)
*
|
2023-01-30 |
2024-10-03 |
Eurofarma Laboratorios S A |
COMPUESTOS FENÓLICOS BLOQUEADORES DE Nav 1.7 Y/O Nav 1.8, SUS PROCESOS DE OBTENCIÓN, SUS COMPOSICIONES, SUS USOS, LOS MÉTODOS DE TRATAMIENTO DE LOS MISMOS Y SUS KITS
|
|
IT202400002560A1
(it)
*
|
2024-02-07 |
2025-08-07 |
Univ Pisa |
Inibitori della proteina rock per uso nel trattamento della fibrosi polmonare
|
|
CN118666857B
(zh)
*
|
2024-06-26 |
2025-02-25 |
江西农业大学 |
一种喹啉类化合物及其在农用杀菌剂中的应用
|
|
CN119060061B
(zh)
*
|
2024-08-26 |
2025-09-16 |
浙江师范大学 |
一类苯并嘧啶硫醚类化合物作为sting蛋白小分子抑制剂的应用
|
|
WO2026062521A2
(en)
|
2024-09-18 |
2026-03-26 |
Institute Of Molecular And Clinical Ophthalmology Basel (Iob) |
Methods and compounds for promoting survival of photoreceptors
|